STOCK TITAN

[8-K] Sabra Healthcare REIT, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Insider Sale: Executive Vice President & Head of Institutional Bank John Leto filed a Form 4 for The Bancorp Inc. (TBBK).

  • Transaction date: 08/01/2025
  • Securities: 50,000 common shares sold (Code “S”)
  • Average price: $60.3482 (price range $60.00-$61.56)
  • Post-sale holdings: 114,111 shares held directly; 3,540 shares held indirectly via 401(k)

No derivative trades were reported, and the filing was made by a single reporting person. Based on the stated amounts, the executive disposed of roughly 30% of his prior direct position (50,000 of ~164,111 shares), reducing—yet still leaving—a sizeable equity stake.

The absence of earnings or corporate event disclosures means this filing is purely a record of insider activity; investors often view sizable insider sales as a potential negative sentiment signal, though motives can vary (liquidity, diversification, preset plans).

Vendita da parte di un insider: Il Vicepresidente Esecutivo e Responsabile della Banca Istituzionale John Leto ha presentato un Modulo 4 per The Bancorp Inc. (TBBK).

  • Data della transazione: 01/08/2025
  • Titoli: 50.000 azioni ordinarie vendute (Codice “S”)
  • Prezzo medio: 60,3482 $ (intervallo di prezzo 60,00 $ - 61,56 $)
  • Detenzioni post-vendita: 114.111 azioni detenute direttamente; 3.540 azioni detenute indirettamente tramite 401(k)

Non sono state segnalate operazioni su strumenti derivati e la comunicazione è stata effettuata da un unico soggetto segnalante. In base alle quantità indicate, l’esecutivo ha ceduto circa il 30% della sua posizione diretta precedente (50.000 su ~164.111 azioni), riducendo ma mantenendo comunque una partecipazione azionaria significativa.

L’assenza di comunicazioni su utili o eventi societari indica che questa segnalazione riguarda esclusivamente l’attività interna; gli investitori spesso interpretano vendite rilevanti da parte di insider come un possibile segnale negativo, anche se le motivazioni possono variare (liquidità, diversificazione, piani prestabiliti).

Venta de insider: El Vicepresidente Ejecutivo y Jefe del Banco Institucional, John Leto, presentó un Formulario 4 para The Bancorp Inc. (TBBK).

  • Fecha de la transacción: 01/08/2025
  • Valores: 50,000 acciones comunes vendidas (Código “S”)
  • Precio promedio: $60.3482 (rango de precio $60.00 - $61.56)
  • Participaciones posteriores a la venta: 114,111 acciones poseídas directamente; 3,540 acciones poseídas indirectamente a través de 401(k)

No se reportaron operaciones con derivados y la presentación fue realizada por una sola persona informante. Según las cantidades indicadas, el ejecutivo vendió aproximadamente el 30% de su posición directa previa (50,000 de ~164,111 acciones), reduciendo pero manteniendo aún una participación accionaria considerable.

La ausencia de divulgaciones sobre ganancias o eventos corporativos significa que esta presentación es únicamente un registro de actividad interna; los inversores a menudo ven ventas significativas de insiders como una posible señal negativa, aunque las motivaciones pueden variar (liquidez, diversificación, planes preestablecidos).

내부자 매도: The Bancorp Inc.(TBBK)의 부사장 겸 기관은행 책임자 John Leto가 Form 4를 제출했습니다.

  • 거래일: 2025년 8월 1일
  • 증권: 보통주 50,000주 매도(코드 “S”)
  • 평균 가격: $60.3482 (가격 범위 $60.00-$61.56)
  • 매도 후 보유 주식: 직접 보유 114,111주; 401(k)를 통한 간접 보유 3,540주

파생상품 거래는 보고되지 않았으며, 제출은 단일 보고자에 의해 이루어졌습니다. 명시된 수량을 기준으로 임원은 이전 직접 보유 주식 약 30%(약 164,111주 중 50,000주)를 처분하여 지분을 줄였지만 여전히 상당한 주식 지분을 유지하고 있습니다.

실적이나 기업 이벤트 공시가 없으므로 이 제출은 내부자 활동 기록에 불과합니다. 투자자들은 대규모 내부자 매도를 부정적인 신호로 볼 수 있지만, 동기는 유동성 확보, 분산 투자, 사전 계획 등 다양할 수 있습니다.

Vente d’initié : John Leto, vice-président exécutif et responsable de la banque institutionnelle, a déposé un formulaire 4 pour The Bancorp Inc. (TBBK).

  • Date de la transaction : 01/08/2025
  • Valeurs mobilières : 50 000 actions ordinaires vendues (Code « S »)
  • Prix moyen : 60,3482 $ (fourchette de prix 60,00 $ - 61,56 $)
  • Positions après la vente : 114 111 actions détenues directement ; 3 540 actions détenues indirectement via un 401(k)

Aucune opération sur dérivés n’a été signalée, et le dépôt a été fait par une seule personne déclarant. Selon les montants indiqués, le dirigeant a cédé environ 30 % de sa position directe antérieure (50 000 sur environ 164 111 actions), réduisant ainsi sa participation tout en conservant une part importante du capital.

L’absence de divulgation de résultats ou d’événements d’entreprise signifie que ce dépôt est uniquement un enregistrement d’activité d’initié ; les investisseurs considèrent souvent les ventes importantes d’initiés comme un signal potentiellement négatif, bien que les motivations puissent varier (liquidités, diversification, plans prédéfinis).

Insider-Verkauf: Executive Vice President und Leiter der Institutionellen Bank John Leto reichte ein Formular 4 für The Bancorp Inc. (TBBK) ein.

  • Transaktionsdatum: 01.08.2025
  • Wertpapiere: 50.000 Stammaktien verkauft (Code „S“)
  • Durchschnittspreis: 60,3482 $ (Preisspanne 60,00 $ - 61,56 $)
  • Bestände nach dem Verkauf: 114.111 Aktien direkt gehalten; 3.540 Aktien indirekt über 401(k) gehalten

Es wurden keine Derivatgeschäfte gemeldet, und die Meldung erfolgte durch eine einzelne meldende Person. Basierend auf den angegebenen Mengen veräußerte der Manager etwa 30 % seiner vorherigen direkten Position (50.000 von ca. 164.111 Aktien), wodurch er seine Beteiligung reduzierte, aber dennoch einen beträchtlichen Aktienanteil behielt.

Das Fehlen von Gewinn- oder Unternehmensereignis-Mitteilungen bedeutet, dass diese Meldung ausschließlich eine Aufzeichnung der Insideraktivität ist; Anleger sehen größere Insider-Verkäufe oft als potenziell negatives Signal, wobei die Motive variieren können (Liquidität, Diversifikation, vorab festgelegte Pläne).

Positive
  • Executive retains 114,111 direct shares, sustaining a meaningful equity alignment with shareholders.
Negative
  • Sale of 50,000 shares (~30% of prior direct holdings) by EVP may be interpreted as a bearish sentiment signal.

Insights

TL;DR: EVP sells 50k shares (~30% stake); modestly bearish insider signal, no related corporate news.

Materiality: While Form 4s don’t directly affect fundamentals, size and rank matter. Leto’s sale (~$3 m) is significant relative to his ownership, signalling some near-term profit-taking at 52-week highs. No 10b5-1 box is marked, suggesting it may not be a pre-scheduled trade. He still controls 117k shares, so alignment remains, but directionally this tilts negative for sentiment-driven investors. Fundamentals unchanged; impact rated negative but not transformational.

TL;DR: Large discretionary sale by key officer; governance impact limited, watch for pattern.

From a governance lens, isolated insider sales are common. The form indicates proper, timely reporting with remaining meaningful ownership, mitigating concerns of total exit. However, a 30% trim outside a disclosed 10b5-1 plan warrants monitoring for recurring sales that could erode perceived alignment. Overall influence on governance risk profile is neutral today, but trends matter.

Vendita da parte di un insider: Il Vicepresidente Esecutivo e Responsabile della Banca Istituzionale John Leto ha presentato un Modulo 4 per The Bancorp Inc. (TBBK).

  • Data della transazione: 01/08/2025
  • Titoli: 50.000 azioni ordinarie vendute (Codice “S”)
  • Prezzo medio: 60,3482 $ (intervallo di prezzo 60,00 $ - 61,56 $)
  • Detenzioni post-vendita: 114.111 azioni detenute direttamente; 3.540 azioni detenute indirettamente tramite 401(k)

Non sono state segnalate operazioni su strumenti derivati e la comunicazione è stata effettuata da un unico soggetto segnalante. In base alle quantità indicate, l’esecutivo ha ceduto circa il 30% della sua posizione diretta precedente (50.000 su ~164.111 azioni), riducendo ma mantenendo comunque una partecipazione azionaria significativa.

L’assenza di comunicazioni su utili o eventi societari indica che questa segnalazione riguarda esclusivamente l’attività interna; gli investitori spesso interpretano vendite rilevanti da parte di insider come un possibile segnale negativo, anche se le motivazioni possono variare (liquidità, diversificazione, piani prestabiliti).

Venta de insider: El Vicepresidente Ejecutivo y Jefe del Banco Institucional, John Leto, presentó un Formulario 4 para The Bancorp Inc. (TBBK).

  • Fecha de la transacción: 01/08/2025
  • Valores: 50,000 acciones comunes vendidas (Código “S”)
  • Precio promedio: $60.3482 (rango de precio $60.00 - $61.56)
  • Participaciones posteriores a la venta: 114,111 acciones poseídas directamente; 3,540 acciones poseídas indirectamente a través de 401(k)

No se reportaron operaciones con derivados y la presentación fue realizada por una sola persona informante. Según las cantidades indicadas, el ejecutivo vendió aproximadamente el 30% de su posición directa previa (50,000 de ~164,111 acciones), reduciendo pero manteniendo aún una participación accionaria considerable.

La ausencia de divulgaciones sobre ganancias o eventos corporativos significa que esta presentación es únicamente un registro de actividad interna; los inversores a menudo ven ventas significativas de insiders como una posible señal negativa, aunque las motivaciones pueden variar (liquidez, diversificación, planes preestablecidos).

내부자 매도: The Bancorp Inc.(TBBK)의 부사장 겸 기관은행 책임자 John Leto가 Form 4를 제출했습니다.

  • 거래일: 2025년 8월 1일
  • 증권: 보통주 50,000주 매도(코드 “S”)
  • 평균 가격: $60.3482 (가격 범위 $60.00-$61.56)
  • 매도 후 보유 주식: 직접 보유 114,111주; 401(k)를 통한 간접 보유 3,540주

파생상품 거래는 보고되지 않았으며, 제출은 단일 보고자에 의해 이루어졌습니다. 명시된 수량을 기준으로 임원은 이전 직접 보유 주식 약 30%(약 164,111주 중 50,000주)를 처분하여 지분을 줄였지만 여전히 상당한 주식 지분을 유지하고 있습니다.

실적이나 기업 이벤트 공시가 없으므로 이 제출은 내부자 활동 기록에 불과합니다. 투자자들은 대규모 내부자 매도를 부정적인 신호로 볼 수 있지만, 동기는 유동성 확보, 분산 투자, 사전 계획 등 다양할 수 있습니다.

Vente d’initié : John Leto, vice-président exécutif et responsable de la banque institutionnelle, a déposé un formulaire 4 pour The Bancorp Inc. (TBBK).

  • Date de la transaction : 01/08/2025
  • Valeurs mobilières : 50 000 actions ordinaires vendues (Code « S »)
  • Prix moyen : 60,3482 $ (fourchette de prix 60,00 $ - 61,56 $)
  • Positions après la vente : 114 111 actions détenues directement ; 3 540 actions détenues indirectement via un 401(k)

Aucune opération sur dérivés n’a été signalée, et le dépôt a été fait par une seule personne déclarant. Selon les montants indiqués, le dirigeant a cédé environ 30 % de sa position directe antérieure (50 000 sur environ 164 111 actions), réduisant ainsi sa participation tout en conservant une part importante du capital.

L’absence de divulgation de résultats ou d’événements d’entreprise signifie que ce dépôt est uniquement un enregistrement d’activité d’initié ; les investisseurs considèrent souvent les ventes importantes d’initiés comme un signal potentiellement négatif, bien que les motivations puissent varier (liquidités, diversification, plans prédéfinis).

Insider-Verkauf: Executive Vice President und Leiter der Institutionellen Bank John Leto reichte ein Formular 4 für The Bancorp Inc. (TBBK) ein.

  • Transaktionsdatum: 01.08.2025
  • Wertpapiere: 50.000 Stammaktien verkauft (Code „S“)
  • Durchschnittspreis: 60,3482 $ (Preisspanne 60,00 $ - 61,56 $)
  • Bestände nach dem Verkauf: 114.111 Aktien direkt gehalten; 3.540 Aktien indirekt über 401(k) gehalten

Es wurden keine Derivatgeschäfte gemeldet, und die Meldung erfolgte durch eine einzelne meldende Person. Basierend auf den angegebenen Mengen veräußerte der Manager etwa 30 % seiner vorherigen direkten Position (50.000 von ca. 164.111 Aktien), wodurch er seine Beteiligung reduzierte, aber dennoch einen beträchtlichen Aktienanteil behielt.

Das Fehlen von Gewinn- oder Unternehmensereignis-Mitteilungen bedeutet, dass diese Meldung ausschließlich eine Aufzeichnung der Insideraktivität ist; Anleger sehen größere Insider-Verkäufe oft als potenziell negatives Signal, wobei die Motive variieren können (Liquidität, Diversifikation, vorab festgelegte Pläne).

false000149229800014922982025-08-042025-08-04

  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 4, 2025
SABRA HEALTH CARE REIT, INC.
(Exact name of registrant as specified in its charter)
 
Maryland 001-34950 27-2560479
(State of
Incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
 
1781 Flight Way
Tustin
CA
92782
(Address of principal executive offices)(Zip Code)
Registrant's telephone number including area code: (888393-8248  
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueSBRAThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02Results of Operations and Financial Condition.
On August 4, 2025, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended June 30, 2025. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished herewith as Exhibits 99.1 and 99.3, respectively, and are specifically incorporated by reference herein.
Item 7.01Regulation FD Disclosure.
The press release furnished herewith as Exhibit 99.1 refers to a supplemental information package that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the supplemental information package is furnished herewith as Exhibit 99.2 and is specifically incorporated by reference herein.
Sabra intends to present the materials attached to this report as Exhibit 99.4 in investor presentations. The furnishing of these materials is not intended to constitute a representation that such furnishing is required by Regulation FD or other securities laws, or that the presentation materials include material investor information that is not otherwise publicly available. In addition, Sabra does not assume any obligation to update such information in the future.
The information in Items 2.02 and 7.01 of this Form 8-K and the information in Exhibits 99.1, 99.2, 99.3 and 99.4 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any filing of Sabra under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01Financial Statements and Exhibits.
 
(d)Exhibits.
99.1
Press Release of Sabra Health Care REIT, Inc., dated August 4, 2025.
99.2
Sabra Health Care REIT, Inc. Supplemental Information Package, dated June 30, 2025.
99.3
Reconciliations of Non-GAAP Financial Measures, dated June 30, 2025.
99.4
Investor Presentation.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
SABRA HEALTH CARE REIT, INC.
Date: August 4, 2025/S/    MICHAEL COSTA
Name: Michael Costa
Title: Chief Financial Officer, Secretary and Executive Vice President




FAQ

How many TBBK shares did EVP John Leto sell?

He disposed of 50,000 common shares on 08/01/2025.

At what price were the TBBK shares sold?

The weighted-average sale price was $60.3482, within a $60.00–$61.56 range.

What is John Leto's remaining stake in The Bancorp Inc.?

After the transaction he holds 114,111 shares directly and 3,540 shares indirectly through a 401(k).

Were any derivative securities involved in this Form 4?

No, no derivative transactions were reported in Table II.

Was the sale under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was executed under a 10b5-1 plan.
Sabra Health Care Reit Inc

NASDAQ:SBRA

SBRA Rankings

SBRA Latest News

SBRA Latest SEC Filings

SBRA Stock Data

4.35B
234.89M
1.28%
99.83%
8.48%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
TUSTIN